Home LiteratureArticle Details
PMID: 10694578 Published · ppublish English Journal Article

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, Connors M

Abstract

A unique cohort of HIV-1-infected long term nonprogressors (LTNP) with normal CD4(+) T cell counts and <50 copies/ml of plasma were prospectively recruited for study. HLA typing revealed a dramatic association between the HLA B*5701 class I allele and nonprogressive infection [85% (11 of 13) vs. 9.5% (19 of 200) in progressors; P < 0. 001]. Antigen-specific CD8(+) T cells were enumerated by flow cytometric detection of intracellular IFN-gamma in response to HIV antigens and HLA B*57-gag tetramer staining. No quantitative differences in the total HIV-specific CD8(+) T cell responses were observed between B*57(+) LTNP and five B*57(+) progressors (P = 0.4). Although similar frequencies of peptide specific CD8(+) T cells were also found, the gag-specific CD8(+) T cell response in the LTNP group was highly focused on peptides previously shown to be B*57-restricted. These findings indicate that, within this phenotypically and genotypically distinct cohort, a host immune factor is highly associated with restriction of virus replication and nonprogressive disease. They also strongly suggest a mechanism of virus specific immunity that directly operates through the B*5701 molecule. Further characterization of qualitative differences in the virus-specific responses that distinguish HLA B*57(+) LTNP from progressors may ultimately define mechanisms of effective immune mediated restriction of virus replication.

MeSH Terms
Alleles Antigens, CD/immunology Antigens, Differentiation, T-Lymphocyte/immunology CD3 Complex/immunology CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology Cohort Studies Flow Cytometry HIV Core Protein p24/immunology HIV Long-Term Survivors HIV Seropositivity/genetics,immunology HLA-B Antigens/genetics Humans Immunophenotyping Interferon-gamma/immunology Lectins, C-Type Leukocytes, Mononuclear/virology Peptides/metabolism Prospective Studies RNA, Viral/blood Virus Replication
Chemicals
Antigens, CD Antigens, Differentiation, T-Lymphocyte CD3 Complex CD69 antigen HIV Core Protein p24 HLA-B Antigens Lectins, C-Type Peptides RNA, Viral Interferon-gamma
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Migueles S A
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Department of Transfusion Medicine, Clinical Center, and Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Sabbaghian M S
Shupert W L
Bettinotti M P
Marincola F M
Martino L
Hallahan C W
Selig S M
Schwartz D
Sullivan J
Connors M
References (36)
36 references, click to expand
  1. Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen.
    J Virol. 2000 Feb;74(4):2023-8 PMID: 10644376
  2. Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection.
    J Infect Dis. 1999 Aug;180(2):526-9 PMID: 10395875
  3. Ankylosing spondylitis and HL-A 27.
    Lancet. 1973 Apr 28;1(7809):904-7 PMID: 4123836
  4. Use of vaccinia virus vectors to study the synthesis, intracellular localization, and action of the human immunodeficiency virus trans-activator protein.
    Virology. 1988 Jun;164(2):450-7 PMID: 2835862
  5. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection.
    J Virol. 1995 Jan;69(1):93-100 PMID: 7983771
  6. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
    N Engl J Med. 1995 Jan 26;332(4):201-8 PMID: 7808485
  7. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.
    N Engl J Med. 1995 Jan 26;332(4):209-16 PMID: 7808486
  8. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.
    N Engl J Med. 1995 Jan 26;332(4):228-32 PMID: 7808489
  9. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor.
    AIDS Res Hum Retroviruses. 1994 Dec;10(12):1703-11 PMID: 7888230
  10. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    J Exp Med. 1995 Apr 1;181(4):1365-72 PMID: 7699324
  11. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
    Nature. 1995 Jun 15;375(6532):606-11 PMID: 7791879
  12. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.
    J Virol. 1995 Sep;69(9):5838-42 PMID: 7637030
  13. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.
    Science. 1995 Nov 10;270(5238):988-91 PMID: 7481804
  14. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.
    J Immunol Methods. 1995 Dec 15;188(1):117-28 PMID: 8551029
  15. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
    Nat Med. 1996 Apr;2(4):405-11 PMID: 8597949
  16. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.
    AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92 PMID: 8743084
  17. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).
    Tissue Antigens. 1995 Nov;46(5):355-67 PMID: 8838344
  18. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.
    AIDS Res Hum Retroviruses. 1996 Dec 10;12(18):1691-8 PMID: 8959245
  19. Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons.
    J Virol. 1996 Dec;70(12):9035-40 PMID: 8971039
  20. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.
    Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1396-401 PMID: 9037064
  21. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.
    Blood. 1997 Aug 1;90(3):1133-40 PMID: 9242545
  22. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
    Science. 1997 Aug 15;277(5328):959-65 PMID: 9252328
  23. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.
    J Gen Virol. 1997 Aug;78 ( Pt 8):1913-8 PMID: 9266987
  24. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection.
    Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9848-53 PMID: 9275214
  25. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    J Clin Invest. 1997 Sep 15;100(6):1581-9 PMID: 9294127
  26. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.
    J Infect Dis. 1997 Oct;176(4):924-32 PMID: 9333150
  27. Association between CCR5 genotype and the clinical course of HIV-1 infection.
    Ann Intern Med. 1997 Nov 15;127(10):882-90 PMID: 9382366
  28. CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Delta32.
    J Virol. 1998 Jul;72(7):6215-7 PMID: 9621092
  29. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome.
    Blood. 1998 Nov 1;92(9):3105-14 PMID: 9787145
  30. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.
    J Virol. 1999 Jan;73(1):797-800 PMID: 9847391
  31. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
    Science. 1999 Mar 12;283(5408):1748-52 PMID: 10073943
  32. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.
    J Immunol. 1999 Jun 1;162(11):6942-6 PMID: 10352317
  33. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
    AIDS. 1999 May 7;13(7):767-77 PMID: 10357375
  34. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.
    Immunity. 1999 Jun;10(6):661-71 PMID: 10403641
  35. Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.
    J Virol. 1999 Sep;73(9):7108-16 PMID: 10438796
  36. High association of an HL-A antigen, W27, with ankylosing spondylitis.
    N Engl J Med. 1973 Apr 5;288(14):704-6 PMID: 4688372
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2000-03-14
Pages
2709-14
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC15994
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com